DONNA FOSTER: Open Payments
NPI 1780877589 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 53 payments from 20 companies in 2025. Trend: 2023 $290 · 2024 $1,520 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $187 |
| Madrigal Pharmaceuticals | 3 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| PFIZER INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 1 | $36 |
Products named: VRAYLAR, REZDIFFRA, REXULTI, LEQVIO, Kerendia, Auvelity, PIFELTRO, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
